A polymeric nanocarrier with acid-activated R9 cell-penetrating peptide selectively delivers drugs at tumor pH (~6.5), significantly enhancing anti-tumor efficacy in mice.
pH 6.5tumor acidity threshold that activates R9 peptide for selective cancer cell drug uptake
What the researchers found
Tumor acidity-activatable polyanionic coating deshielded at pH 6.5, re-exposing R9 peptide and significantly increasing intracellular drug concentration in tumor cells. The system remarkably promoted anti-tumor efficiency in tumor-bearing mice.
Why it matters
Tumor selectivity is the holy grail of cancer drug delivery. By exploiting the universal feature of tumor acidity to control drug release, this system could reduce off-target toxicity while increasing drug concentration at the tumor.
The numbers in context
R9 activated at tumor pH (~6.5); inactive at normal pH (7.4); selective tumor uptake in vivo.
How the study worked
Fabrication of PEG-PHEP-R9 nanoparticles coated with pH-responsive polyanionic polyphosphoester. In vitro uptake studies at pH 7.4 vs 6.5 in 4T1 cells. In vivo anti-tumor efficacy in tumor-bearing mice.
Who was studied
Cancer cell lines and tumor-bearing animal models
What this study cannot tell us
Tested in a single tumor model (4T1). pH variations within tumors may affect consistency of activation. Manufacturing complexity of multi-layer nanoparticles could challenge clinical translation.
How to read the evidence
Proof-of-concept with in vitro mechanism confirmation and in vivo efficacy data. Single tumor model limits generalizability.
When this study was published
Published in 2020. pH-responsive drug delivery systems continue to advance toward clinical testing.
The bigger picture
Smart drug delivery systems that respond to the tumor microenvironment represent a growing field. pH-responsive systems exploit one of the most reliable differences between tumor and normal tissue, making them broadly applicable across cancer types.
Questions still open
- How does this system perform across different tumor types with varying acidity levels?
- Can the pH activation threshold be tuned for different clinical applications?
- What is the safety profile of the polymer components in long-term use?
Common questions
Why are tumors acidic?
What is an R9 peptide?
Read the original research
A polymeric nanocarrier with a tumor acidity-activatable arginine-rich (R9) peptide for enhanced drug delivery.
Biomaterials science, 8(8), 2255-2263
Citation
Zhang, Liting; Jiang, Chengtao; Zeng, Fanjun; Zhou, Haiyu; Li, Dongdong; He, Xinyu; Shen, Song; Yang, Xianzhu; Wang, Jun. (2020). A polymeric nanocarrier with a tumor acidity-activatable arginine-rich (R9) peptide for enhanced drug delivery.. Biomaterials science, 8(8), 2255-2263. https://doi.org/10.1039/d0bm00069h